We are utilizing our passion, expertise, resources, and relationships to build an ecosystem of technology partners. Together, we will deliver industry-leading digital health solutions that empower people living with chronic conditions to build healthier habits into their daily lives.1
Changing Habits, Changing Lives
For the
Patient and Caregiver
who know that they need to make healthier choices and are looking for support and encouragement.1
For the
Healthcare Professional
who recognizes that their patients may be struggling and is looking for ways to help them between office visits.1
For the
Payer
who understands the impact of patient behavior on outcomes and costs and is looking for innovative technology backed by evidence and results.1
This Is the Next Chapter in a Legacy of Innovative Technology Solutions
We know from experience that innovative technology has the power to transform the practice of medicine. We believe that digital health is the next frontier that can help improve the lives of people living with chronic diseases.1
Built on our 6 core capabilities, we have a differentiated digital health offering1:
Account Partnering:
The breadth and expertise to cultivate valuable partnerships with both companies and payers
Unique Contracting Exploration:
A history of robust partnerships that underlie a portfolio of innovative health solutions
Digital-Ready Infrastructure:
The established infrastructure to rapidly launch and scale digital interventions
Holistic User Experience:
A commitment to deliver a complete, patient-centered user experience
Focus on Unmet Needs:
An investment in chronic disease management that considers behavior to be a vital factor in disease outcomes
Evidence Generation:
An emphasis on real-world data that showcase the impact of digital interventions on clinical, behavioral, and economic outcomes
Contact Us
To learn more about how Sanofi is using digital health solutions to help improve outcomes and reduce the costs of chronic conditions, please click below or contact your Sanofi Account Director.
Intended for use with payers, formulary committees, or other similar entities for purposes of population-based drug selection, coverage, and/or reimbursement decision-making, pursuant to FD&C Act Section 502(a).
Reference: Data on file. Sanofi US.